Search Within

GME, Medicine

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (59)
  2. Journal Article (36)
  3. Research Letter (5)
  4. Correspondence (2)
  5. Review (2)
  6. Editorial (1)
Groups
  1. CTCR Scholars (105)
  2. Department of Medicine (105)
  3. Graduate Medical Education (105)
  4. MSK Grad Students (105)
  5. Master of Science in Clinical and Translational Cancer Research (105)
  6. Survivorship Research (84)

More Groups

People
  1. Miguel-Angel Perales (52)
  2. Parastoo Dahi (48)
  3. Michael Scordo (47)
  4. Gunjan Shah (45)
  5. Richard Lin (42)
  6. Maria Palomba (41)

More People

Years
  1. 2025 (9)
  2. 2024 (26)
  3. 2023 (37)
  4. 2022 (22)
  5. 2021 (7)
  6. 2018 (2)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (18)
  3. Transplantation and Cellular Therapy (7)
  4. Blood Advances (4)
  5. Bone Marrow Transplantation (4)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Hematology (33)
  2. American Society of Clinical Oncology (19)
  3. Elsevier Inc. (11)
  4. Nature Publishing Group (10)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (4)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers
    Meeting Abstract

    Balogun, F.; Altoe, M.; O'Connor, C.; Chowdhury, N.; Cercek, A.; Lee, C. K.; Foote, M. B.; Kim, D.; Maron, S. B.; Kim, D. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profile in patients receiving CAR T‐cell therapy for aggressive B‐cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Lin, R. J.; Imber, B.; Parascondola, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Durable response after olaparib treatment for perihilar cholangiocarcinoma with germline BRCA2 mutation
    Journal Article

    Costa, B. A.; Tallón de Lara, P.; Park, W.; Keane, F.; Harding, J. J.; Khalil, D. N.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Pancreatic cancer: BRCA targeted therapy and beyond
    Review

    Keane, F.; O’Connor, C. A.; Park, W.; Seufferlein, T.; O’Reilly, E. M.
    Cancers (2023)

    Fulltext@MSK | Save
  • Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: Opportunity and challenge
    Journal Article

    Keane, F.; Bajwa, R.; Selenica, P.; Park, W.; Roehrl, M. H.; Reis-Filho, J. S.; Mandelker, D.; O’Reilly, E. M.
    npj Precision Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC)
    Meeting Abstract

    Keane, F.; Schoenfeld, J. D.; Crowley, F.; O'Connor, C. A.; White, C.; Schwartz, C.; Brenner, R.; Larsen, M.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save